<?xml version="1.0" encoding="UTF-8"?>
<p>In 2002, the outbreak of SARS in Guangdong Province, China led to the discovery of SARS‐CoV, a highly pathogenic CoV, as the causative pathogen of the epidemic [
 <xref rid="ene14277-bib-0007" ref-type="ref">7</xref>]. Although the virus is primarily a respiratory pathogen, there are reports of neurological manifestations, such as epileptic seizures and encephalitis, that may suggest a CNS involvement of the infection [
 <xref rid="ene14277-bib-0008" ref-type="ref">8</xref>, 
 <xref rid="ene14277-bib-0009" ref-type="ref">9</xref>] (Table 
 <xref rid="ene14277-tbl-0001" ref-type="table">1</xref>). Complementing these reports, post‐mortem neuropathological studies have detected the SARS‐CoV N protein and RNA polymerase gene fragment in neurons of infected patients and pathological changes such as brain tissue edema and vasculitis of cerebral veins [
 <xref rid="ene14277-bib-0010" ref-type="ref">10</xref>].
</p>
